Skip to main navigation Skip to search Skip to main content

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis.

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1154-1155
Number of pages2
JournalNew England Journal of Medicine
Volume390
Issue number12
DOIs
StatePublished - Mar 21 2024

Cite this